Literature DB >> 21632842

Treatment of acute myeloid leukemia in the elderly.

Elihu H Estey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21632842      PMCID： PMC3105638          DOI： 10.3324/haematol.2011.044776

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia.

Authors:  Keith Wheatley; Richard Gray
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

2.  Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.

Authors:  W G Woods; N Kobrinsky; J D Buckley; J W Lee; J Sanders; S Neudorf; S Gold; D R Barnard; J DeSwarte; K Dusenbery; D Kalousek; D C Arthur; B J Lange
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

Review 3.  Reduced-intensity conditioning transplantation in myeloid malignancies.

Authors:  Rainer Storb
Journal:  Curr Opin Oncol       Date:  2009-06       Impact factor: 3.645

4.  The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.

Authors:  M Mohty; H de Lavallade; P Ladaique; C Faucher; N Vey; D Coso; A-M Stoppa; J-A Gastaut; D Blaise
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

5.  Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

Authors:  Elihu Estey; Marcos de Lima; Raoul Tibes; Sherry Pierce; Hagop Kantarjian; Richard Champlin; Sergio Giralt
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

6.  Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria.

Authors:  Raphael Itzykson; Claude Gardin; Cécile Pautas; Xavier Thomas; Pascal Turlure; Emmanuel Raffoux; Christine Terré; Pierre Fenaux; Sylvie Castaigne; Hervé Dombret; Nicolas Boissel
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

7.  Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.

Authors:  Mikkael A Sekeres; Paul Elson; Matt E Kalaycio; Anjali S Advani; Edward A Copelan; Stefan Faderl; Hagop M Kantarjian; Elihu Estey
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

8.  Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.

Authors:  Marco Mielcarek; Barry E Storer; Brenda M Sandmaier; Mohamed L Sorror; David G Maloney; Effie Petersdorf; Paul J Martin; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

9.  Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.

Authors:  Mats Brune; Sylvie Castaigne; John Catalano; Kurt Gehlsen; Anthony D Ho; Wolf-Karsten Hofmann; Donna E Hogge; Bo Nilsson; Reuven Or; Ana I Romero; Jacob M Rowe; Bengt Simonsson; Ruth Spearing; Edward A Stadtmauer; Jeff Szer; Elisabeth Wallhult; Kristoffer Hellstrand
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

10.  Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.

Authors:  Claude Gardin; Pascal Turlure; Thierry Fagot; Xavier Thomas; Christine Terre; Nathalie Contentin; Emmanuel Raffoux; Stephane de Botton; Cecile Pautas; Oumedaly Reman; Jean-Henri Bourhis; Pierre Fenaux; Sylvie Castaigne; Mauricette Michallet; Claude Preudhomme; Thierry de Revel; Dominique Bordessoule; Herve Dombret
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113
View more
  2 in total

1.  Particular clinical and therapeutical aspects in acute myeloid leukemia in elderly patients.

Authors:  Andrei Colita; Anca Colita; Nicoleta Mariana Berbec; Silvana Angelescu; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2011-10

2.  A model for the functional assessment of elderly with myeloid neoplasms.

Authors:  Ana Lúcia Ippolito Carbonell; Renata Maceu Salhab; Viviana Giampaoli; Maysa Seabra Cendoroglo; Maria de Lourdes Chauffaille
Journal:  Rev Bras Hematol Hemoter       Date:  2015-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.